RIVERSIDE, Calif. — Physicist Nathaniel Gabor at the University of California, R...
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT...
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemoratin...
Hippocratic AI emerged from stealth mode approximately a year ago, unveiling its...
Bayer’s recent announcement regarding its intention to seek regulatory approval ...
Bionomics plans to meet with the FDA following positive topline data from the Ph...
Capstan Therapeutics has secured $175m Series B financing to advance its lead in...
Panellists discuss opportunities and challenges in cell and gene therapies at th...
Biotech executives discuss why developing gene therapies for central nervous sys...
Merck KGaA has announced an investment of over €300m ($326.1m) to establish a ne...
Lilly says that the FDA wants to look closer at efficacy implications of the Pha...
Different therapeutic approaches against antibiotic-resistant bacteria were high...
Nouscom is part of a cancer vaccine landscape that has recently jump-started fol...
The Phase III KEYLYNK-006 study evaluating a Keytruda/Lynparza combination treat...
Deals involving research into molecular glues have skyrocketed this year as big ...
Many important medicines, such as antibiotics and anticancer drugs, are derived ...
